Biomarkers are naturally occurring molecules that indicate normal biological processes or disease states. Biomarkers are pivotal in cancer research, where immunohistochemical (IHC) detection of specific biomarkers helps explore disease development and progression mechanisms.
Download the eBook
A key benefit of IHC in cancer studies is its ability to offer visual context for tumors and their surrounding microenvironment, uncovering unique insights that can guide appropriate therapeutic interventions. Accurate biomarker detection using IHC relies on highly specific, thoroughly validated antibodies.
Cell Signaling Technology follows the Hallmarks of Antibody Validation™, a set of strategies designed to confirm the specificity, sensitivity, and functionality of antibodies in any assay. This tailored validation process helps to ensure reliable results.
This free eBook guide from Cell Signaling Technology categorizes essential cancer biomarkers into seven groups, highlighting the importance of studying various biomarkers simultaneously to advance cancer understanding.
Download the eBook